
6th Biennial Scientic Conference of the African Health Economics and Policy Association (AfHEA)
Theme: Towards Resilient Health Systems in Africa: The Role of Health Economics and Policy Research.
Bryony Simmons1, Elisa Sicuri2 and Lesong Conteh1, (1)London School of Economics &
Political Science, London, United Kingdom, (2)London School of Economics & Political Science,
United Kingdom, Zoly Rakotomalala1, Jean-Marc Kutz2, Raphael Rakotozandrindrainy3,
Tahinamandranto Rasamoelina4, Rivo Rakotoarivelo5 and Daniela Fusco2, (1)Centre
Hospitalier Universitaire de Mahajanga, Madagascar, (2)Bernhard Nocht Institute for Tropical
Medicine, Germany, (3)University of Antananarivo, Madagascar, (4)Centre d’Infectiologie
Charles Merieux, Madagascar, (5)Centre Hospitalier Universitaire de Fianarantsoa,
Madagascar, Marie Paul Nisingizwe1, Jean Damascene Makuza1, Bethany Hedt-Gauthier2,
Janvier Serumondo3, Eric Remera3, Sabin Nsanzimana3, Naveed Janjua1, Nick Bansback1
and Michael Law1, (1)University of British Columbia, Canada, (2)Harvard Medical School, (3)
Rwanda Biomedical Centre, Rwanda, Rose Nadege Penda Noelle Mbaye1, Fatoumata Diene
Sarr2, Hamidou Thiam2, Rokhaya Diop2, Mam Coumba Diouf2, Mohamed Abass Yugo2,
Ahmed Badji3, Ahmadou Bouya Ndao4, Abdoul Kane5, Amadou Alpha Sall2 and Cheikh
Loucoubar2, (1)Institut Pasteur of Dakar, Dakar, Senegal, (2)Institut Pasteur of Dakar, Senegal,
(3)Département socio-anthropologie université Cheikh Anta Diop de Dakar, Senegal, (4)
District Sanitaire de Sokone, Senegal, (5)Clinique cardiologie de l’hôpital le Dantec, Senegal
Francesco Ramponi1, Pakwanja Twea2, Benson Chilima2, Dominic Nkhoma3, Isabel Kazanga
Chiumia3, Gerald Manthalu2, Joseph Mfutso-Bengo3, Paul Revill1, Mike Drummond4 and
Mark Sculpher4, (1)Centre for Health Economics, University of York, York, United Kingdom, (2)
Ministry of Health, Malawi, (3)Health Economics & Policy Unit (HEPU), College of Medicine,
University of Malawi, Malawi, (4)Centre for Health Economics, University of York, United
Kingdom.
Accurate diagnostic tests are central for the management of communicable and non-
communicable diseases at both the patient level (eg, for the diagnosis, guided therapy, and
management of disease) and the population level (eg, for disease detection and surveillance).
The availability and timely access to diagnostics are therefore essential to reducing the
burden of disease and contributing towards health system strengthening and sustainable
development. Despite this, access to appropriate and quality disease diagnostic testing is poor
and inequitable in many parts of the world.
Diagnostic value chains or frameworks have been proposed to understand the chain of events
between the design and development of a new diagnostic testing device and its adoption
by end users. Challenges to the demand and supply of diagnostics exist across all steps of
this value chain, with each representing a potential point of failure for successful adoption of
technologies. These challenges are compounded by a lack of reliable and comprehensive data
to inform planning and support policy decisions.
This session will discuss the diagnostics value chain, focusing largely on diagnosis of infectious